EODData

FRA, DAP: Danaher Corporation

02 Oct 2026
LAST:

188.0

CHANGE:
 5.25
OPEN:
188.4
HIGH:
188.4
ASK:
0.0
VOLUME:
0
CHG(%):
2.72
PREV:
193.3
LOW:
188.0
BID:
0.0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Oct 26188.4188.4188.0188.00
01 Oct 26196.1196.1193.3193.30
30 Sep 26199.9200.0197.0197.0201
29 Sep 26198.9200.8197.2198.7263
28 Sep 26197.0200.0195.2200.00
25 Sep 26196.3196.6193.4196.6505
24 Sep 26193.1195.2192.6195.2190
23 Sep 26192.5194.8192.5193.5224
22 Sep 26187.6191.0185.6191.0437
21 Sep 26186.2188.2183.0188.2865

PROFILE

Name:Danaher Corporation
About:Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a partnership with AstraZeneca PLC to develop and commercialize diagnostic tools and tests. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and
Sector:Healthcare
Address:2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701
Website:https://www.danaher.com
ISIN:US2358511028
LEI:S4BKK9OTCEWQ3YHPFM11

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:38.52 
Forward P/E:18.93 
PEG Ratio:0.64 
Price to Sales:5.19 
Price to Book:2.87 
Profit Margin:0.16 
Operating Margin:0.20 
Return on Assets:0.04 
Return on Equity:0.08 
DivYield:0.01 
Div/Share:1.18 
Revenue:21.451B 
EBITDA:7.772B 
Shares:716.05M 
Market Cap:134.618B 

TECHNICAL INDICATORS

MA5:195.373.9%
MA10:194.133.3%
MA20:185.741.2%
MA50:180.554.1%
MA100:169.7010.8%
MA200:174.307.9%
STO14:46.89
RSI14:69.17 
WPR14:-51.50
MTM14:11.30
ROC14:0.06 
ATR:4.33 
Week High:200.806.8%
Week Low:188.000.0%
Month High:200.806.8%
Month Low:172.507.9%
Year High:208.3010.8%
Year Low:137.8036.4%
Volatility:19.49 

RECENT SPLITS

Date Ratio
21 May 20042-1

RECENT DIVIDENDS

Date Amount
26 Jun 2026$0.35
27 Mar 2026$0.35
26 Sep 2025$0.27
27 Jun 2025$0.27
28 Mar 2025$0.27
27 Dec 2024$0.23
27 Sep 2024$0.23
28 Jun 2024$0.23
27 Mar 2024$0.23
28 Dec 2023$0.21